311 related articles for article (PubMed ID: 25399481)
1. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne.
Thielitz A; Lux A; Wiede A; Kropf S; Papakonstantinou E; Gollnick H
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):789-96. PubMed ID: 25399481
[TBL] [Abstract][Full Text] [Related]
2. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
3. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.
Thiboutot DM; Shalita AR; Yamauchi PS; Dawson C; Kerrouche N; Arsonnaud S; Kang S
Arch Dermatol; 2006 May; 142(5):597-602. PubMed ID: 16702497
[TBL] [Abstract][Full Text] [Related]
4. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.
Poulin Y; Sanchez NP; Bucko A; Fowler J; Jarratt M; Kempers S; Kerrouche N; Dhuin JC; Kunynetz R
Br J Dermatol; 2011 Jun; 164(6):1376-82. PubMed ID: 21457209
[TBL] [Abstract][Full Text] [Related]
5. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Thiboutot D; Arsonnaud S; Soto P
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
[TBL] [Abstract][Full Text] [Related]
8. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
[TBL] [Abstract][Full Text] [Related]
9. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
[TBL] [Abstract][Full Text] [Related]
10. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle.
Pariser DM; Thiboutot DM; Clark SD; Jones TM; Liu Y; Graeber M;
Cutis; 2005 Aug; 76(2):145-51. PubMed ID: 16209161
[TBL] [Abstract][Full Text] [Related]
12. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%.
Thielitz A; Sidou F; Gollnick H
J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):747-53. PubMed ID: 17567301
[TBL] [Abstract][Full Text] [Related]
13. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
14. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study.
Kawashima M; Harada S; Loesche C; Miyachi Y
J Dermatol Sci; 2008 Mar; 49(3):241-8. PubMed ID: 18063345
[TBL] [Abstract][Full Text] [Related]
15. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline.
Alirezai M; George SA; Coutts I; Roseeuw DI; Hachem JP; Kerrouche N; Sidou F; Soto P
Eur J Dermatol; 2007; 17(1):45-51. PubMed ID: 17324827
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N
J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800
[TBL] [Abstract][Full Text] [Related]
18. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
[TBL] [Abstract][Full Text] [Related]
19. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
Zhang JZ; Li LF; Tu YT; Zheng J
J Dermatolog Treat; 2004 Dec; 15(6):372-8. PubMed ID: 15764049
[TBL] [Abstract][Full Text] [Related]
20. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
Gold LS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
